Investigation announced for Investors in shares of Novavax, Inc. (NASDAQ: NVAX)

An investigation was announced over potential securities laws violations by Novavax, Inc. in connection with certain financial statements.

Investors who purchased shares of Novavax, Inc. (NASDAQ: NVAX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Novavax, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Gaithersburg, MD based Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. Novavax, Inc. reported that its annual Total Revenue rose from $18.66 million in 2019 to $475.59 million in 2020, and that its Net Loss increased from $132.69 million in 2019 5o $418.25 million in 2020.

On October 19, 2021, Politico published an article entitled “’They rushed the process’: Vaccine maker’s woes hamper global inoculation campaign.” The Politico article reported, in relevant part, that Novavax “faces significant hurdles in proving it can manufacture a shot that meets regulators’ quality standards” with respect to Covid-19 vaccination. The Politico article cited anonymous sources as stating that Novavax’s “issues are more concerning than previously understood” and that the Company could take until the end of 2022 to resolve its manufacturing issues and win regulatory authorizations and approvals.

Shares of Novavax, Inc. (NASDAQ: NVAX) declined from $174.64 per share on October 15, 2021, to $121.35 per share on October 20, 2021.

Those who purchased shares of Novavax, Inc. (NASDAQ: NVAX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.